期刊文献+

HPLC法测定沙美特罗替卡松粉吸入剂中沙美特罗和丙酸氟替卡松的含量 被引量:1

HPLC Determination Content of Salmeterol and Fluticasone Propionate in Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation
下载PDF
导出
摘要 建立了紫外检测器与荧光检测器串联HPLC法测定沙美特罗替卡松粉吸入剂中的沙美特罗和丙酸氟替卡松的含量。采用C18色谱柱;以甲醇-乙腈-0.05mol/L乙酸铵溶液(30:30:40)为流动相;沙美特罗采用荧光检测器,激发波长344nm,发射波长441nm;丙酸氟替卡松采用紫外检测器,检测波长239nm。沙美特罗和丙酸氟替卡松分别在4.00~499.98ng和7.94~993.40ng进样量范围内,进样量与峰面积线性关系良好;回收率为100.2%和99.8%。 A HPLC method was established with UV detector and fluorescence detector combination for the determination content of Salmeterol and Fluticasone Propionate in Salemeterol Xinafoate and Fluticasone Propionate Powder for nhalation by combining by using C18 as chromatographic column,and ethanol-acetonitrile-0.05mol/L ammonium acetate solution(30:30:40) as mobile phase.The excitation wavelength was 344nm,and emission wavelength was 441nm for Salmeterol with fluorescence detector,while the detection wavelength was 239nm for Fluticase Propionate with UV detector.The calibration curves for Salmeterol and Fluticasone Propionate were linear in the concentration ranges of 4.00??499.98ng and 7.94??993.40ng respectively.The recovery rate was 100.2% and 99.8% for Salmeterol and Fluticasone Propionate.
作者 江竹莲
出处 《精细化工原料及中间体》 2011年第7期30-32,12,共4页 Fine Chemical Industrial Raw Materials & Intermediates
关键词 HPLC 沙美特罗替卡松粉吸入剂 沙美特罗 丙酸氟替卡松 荧光检测器 HPLC Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation Salmeterol Fluticasone Propionate Fluorescence detector
  • 相关文献

参考文献3

  • 1林士军,王桂杰,刘玉春,董惠翔.舒利迭治疗支气管哮喘的临床观察[J].临床肺科杂志,2009,14(2):188-189. 被引量:78
  • 2Yonatan Michael,,Babur Z.Chowdhry,,Ian C.Ashurst,et al.The physico-chemical properties of salmeterol andfluticasone propionate in different solvent environments[].Saudi Pharma-ceutical Journal.2010
  • 3Lantider Kasaye,,Ariaya Hymete,Abdel-Maaboud I Mo-hamed.HPTLC-densitometric method for simultaneous determi-nation of salmeterol xinafoate and fluticasone propionate in dry powder inhalers[].International Journal of Pharmaceutics.2000

二级参考文献10

  • 1段建明,安新,张继艳.沙美特罗联合氟替卡松治疗咳嗽变异型哮喘38例临床观察[J].临床肺科杂志,2006,11(6):714-714. 被引量:29
  • 2Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immuno1,2004, 115 ( 1 ) :59 -65.
  • 3Bousquet J, Jeffery PK. Busse WW, et al. Asthma from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med,2000,161 (5) :1720 -1745.
  • 4Van den Berg N J, Ossip MS, Hederos CA, et al. Salmeterol/fluticasone propionate (50/100 micog) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma. Pediatric Pulmonology ,2000,30 (2) :97 - 105.
  • 5Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med, 2004,170 ( 8 ) : 836 - 844.
  • 6Dahl R, Chuchalin A, Gor D, et al. EXCEL: A randomised trial comparing salmeteroL/fluticasone propionate and formoterolfbudesonide combinations in adults with persistent asthma. Respir Med, 2006,100(7) :1152 - 1162.
  • 7GINA 2006. http://www. ginasthma, com.
  • 8Jeannin P, Lecoanet S, Delneste Y, et al. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol, 1998,160 (7) :3555 -3561.
  • 9中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核和呼吸杂志,2003,26(3):132-138. 被引量:3561
  • 10中华医学会呼吸病学分会哮喘学组,殷凯生,林江涛.第四届全国支气管哮喘学术会议纪要[J].中华结核和呼吸杂志,2003,26(3):175-177. 被引量:23

共引文献77

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部